Inventor · disambiguated record
Ernesto Javier Munoz
Also filed as: MUNOZ ERNESTO · MUNOZ ERNESTO J · MUNOZ ERNESTO JAVIER · MUÑOZ ERNESTO J
8 granted patents·13 pending applications·42 citations·filing 2009–2025
85Inventor score
Top patents by PatentIndex Score
21 records- 0190US8394621B2Modified photosynthetic microorganisms for producing triglyceridesROBERTS JAMES·Filed 2009·Granted Mar 12, 2013·12 cites·20 claims
- 0288US8394614B2Modified photosynthetic microorganisms for producing triglyceridesROBERTS JAMES·Filed 2010·Granted Mar 12, 2013·8 cites·21 claims
- 0385US11548941B2Safe and effective method of treating psoriasis with anti-IL-23 specific antibodyJANSSEN BIOTECH INC·Filed 2019·Granted Jan 10, 2023·4 cites·31 claims
- 0482US9073946B2Anti-viral compoundsKINETA INC·Filed 2013·Granted Jul 7, 2015·3 cites·10 claims
- 0582US9029120B2Modified photosynthetic microorganisms for producing triglyceridesMATRIX GENETICS LLC·Filed 2013·Granted May 12, 2015·5 cites·14 claims
- 0679US9523096B2Modified photosynthetic microorganisms for producing lipidsROBERTS JAMES·Filed 2011·Granted Dec 20, 2016·4 cites·20 claims
- 0779US8980613B2Modified photosynthetic microorganisms for producing lipidsROBERTS JAMES·Filed 2011·Granted Mar 17, 2015·3 cites·4 claims
- 0872US9937230B2Ophthalmic uses of toxin-based therapeutic peptides and pharmaceutical compositions thereofKINETA ONE LLC·Filed 2014·Granted Apr 10, 2018·3 cites·12 claims
- 0962US2025340660A1Anti-cd30l antibodies, formulations therefor, and uses thereofPROMETHEUS BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1062US2025243289A1Methods of treating inflammatory diseases with combination of tl1a inhibitors and il23 inhibitorsPROMETHEUS BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1161US2021215717A1Sustained Response Predictors After Treatment with Anti-IL23 AntibodyJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 1261US2022289835A1Safe and effective method of treating psoriasis with anti-il-23 specific antibodyJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1357US2023212280A1IL-23 Specific Antibodies for the Treatment of Systemic SclerosisJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1456US2024336691A1Anti-tl1a antibody compositions and methods of treatment in the lungPROMETHEUS BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1550US2020025776A1Sustained Response Predictors After Treatment With Anti-IL23 Specific AntibodyJANSSEN BIOTECH INC·Filed 2019·Application pending·0 cites
- 1648US2015342932A1Anti-viral compoundsKINETA INC·Filed 2015·Application pending·0 cites
- 1747US2023003719A1Materials and methods for inflammatory molecular markersJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 1847US2023014092A1Materials and methods for monitoring inflammationJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 1942US2025163143A1IL-23 Specific Antibodies for the Treatment of Systemic SclerosisJANSSEN BIOTECH INC·Filed 2025·Application pending·0 cites
- 2040US2016338967A1Sustained release depot formulations of therapeutic proteins, and uses thereofKINETA ONE LLC·Filed 2014·Application pending·0 cites
- 2140US2016000869A1Methods of treating ipex syndrome using toxin-based pharmaceutical compositionsKINETA ONE LLC·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →